BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 25917195)

  • 1. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
    Chiu YC; Hsiao TH; Chen Y; Chuang EY
    BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival.
    Chiu YC; Wang LJ; Lu TP; Hsiao TH; Chuang EY; Chen Y
    BMC Bioinformatics; 2017 Feb; 18(1):132. PubMed ID: 28241741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives.
    Cheng DL; Xiang YY; Ji LJ; Lu XJ
    Tumour Biol; 2015 Feb; 36(2):479-88. PubMed ID: 25604144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancerin: A computational pipeline to infer cancer-associated ceRNA interaction networks.
    Do D; Bozdag S
    PLoS Comput Biol; 2018 Jul; 14(7):e1006318. PubMed ID: 30011266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
    Ergun S; Oztuzcu S
    Tumour Biol; 2015 May; 36(5):3129-36. PubMed ID: 25809705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of computational methods for identifying miRNA-mediated RNA-RNA crosstalk.
    Li Y; Jin X; Wang Z; Li L; Chen H; Lin X; Yi S; Zhang Y; Xu J
    Brief Bioinform; 2019 Jul; 20(4):1193-1204. PubMed ID: 29077860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of an oesophageal cancer-specific ceRNA network based on miRNA, lncRNA, and mRNA expression data.
    Xue WH; Fan ZR; Li LF; Lu JL; Ma BJ; Kan QC; Zhao J
    World J Gastroenterol; 2018 Jan; 24(1):23-34. PubMed ID: 29358879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering and Constructing ceRNA-miRNA-Target Gene Regulatory Networks during Anther Development in Maize.
    Li Z; An X; Zhu T; Yan T; Wu S; Tian Y; Li J; Wan X
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types.
    Xu J; Li Y; Lu J; Pan T; Ding N; Wang Z; Shao T; Zhang J; Wang L; Li X
    Nucleic Acids Res; 2015 Sep; 43(17):8169-82. PubMed ID: 26304537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics.
    Sanchez-Mejias A; Tay Y
    J Hematol Oncol; 2015 Mar; 8():30. PubMed ID: 25888444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ceRNA in cancer: possible functions and clinical implications.
    Qi X; Zhang DH; Wu N; Xiao JH; Wang X; Ma W
    J Med Genet; 2015 Oct; 52(10):710-8. PubMed ID: 26358722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CERNA SEARCH METHOD IDENTIFIED A MET-ACTIVATED SUBGROUP AMONG EGFR DNA AMPLIFIED LUNG ADENOCARCINOMA PATIENTS.
    Kabat H; Tunkle L; Lee I
    Pac Symp Biocomput; 2017; 22():438-448. PubMed ID: 27896996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.
    Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W
    Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing endogenous RNA networks and gastric cancer.
    Guo LL; Song CH; Wang P; Dai LP; Zhang JY; Wang KJ
    World J Gastroenterol; 2015 Nov; 21(41):11680-7. PubMed ID: 26556995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
    Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
    Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-guided quantitative analysis of microRNA-mediated regulation on competing endogenous RNAs using a synthetic gene circuit.
    Yuan Y; Liu B; Xie P; Zhang MQ; Li Y; Xie Z; Wang X
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3158-63. PubMed ID: 25713348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.